J&J (NYSE: JNJ) said to offer hip case accord which may exceed $2B
- Wall Street rises more than one percent as bank, tech stocks jump
- Twitter (TWTR) Announces Changes of 140-Character Limit
- U.S. new home sales race to eight-year high, prices surge
- Exclusive: Monsanto to reject Bayer bid, seek higher price - sources
- Herbalife (HLF) Said to Reach Preliminary Settlement with FTC - NYP
Johnson & Johnson (NYSE: JNJ) said to offer hip case accord which may exceed $2 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Janssen (JNJ) Announces FDA Approval of Expanded INVOKAMET Indication
- Bank of America $1.27 billion U.S. mortgage penalty is voided
- Standpoint Research Starts Johnson & Johnson (JNJ) at Sell
Create E-mail Alert Related CategoriesGeneral News, Litigation
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!